A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples